Join us for a special AD/PD™ Live Journal Club featuring Dr. Stefan Teipel, who will guide us through an exciting new special issue exploring the cutting edge of early Alzheimer’s disease detection.
Dr. Teipel will highlight critical research gaps, including diagnostic innovation needs, biomarker applications across diverse ethnic groups, and the essential role of patients and caregivers in study design.
Date: 15 December 2025 
Time: 16:00 CET
Reserve your spot today – we look forward to seeing you there!
Agenda
- Welcome
Prof. Perry introduces the speaker. - Presentation
Dr. Teipel discusses the featured article:
“Early detection of Alzheimer’s disease: From multiplex assays and imaging to point-of-care devices and AI-based functional monitoring” - Discussion & Q&A
Moderated by Prof. Perry.
Speakers
Prof. Stefan Teipel
German Center of Neurodegenerative Diseases (DZNE)
Stefan Teipel is psychiatrist and senior group leader for clinical research at the DZNE Rostock/Greifswald. His focus is on (i) transferring biomarkers and interventions from methodological development into routine care, including prognostic and diagnostic imaging markers, (ii) developing explainable AI and digital monitoring as patient-powered real-world endpoints and ecologically valid assistive systems, and involving patients and caregivers for technology co-design. He leads the Memory Clinic of the University Medicine Rostock.
Moderator
Prof. George Perry
Professor – Editor-in-Chief·Journal of Alzheimer’s Disease
George Perry, Ph.D., is a Professor and the Semmes Foundation Distinguished University Chair in Neurobiology at the University of Texas at San Antonio. He earned his Ph.D. in Marine Biology from Scripps Institution of Oceanography in 1979 and conducted postdoctoral research at Baylor College of Medicine. A leading Alzheimer’s disease researcher with over 1,000 publications, Dr. Perry is among the top 100 most-cited neuroscientists and a recognized figure in free radical research. He is editor-in-chief of the Journal of Alzheimer’s Disease and has received numerous prestigious awards, including the Denham Harmon Lifetime Achievement Award and the Zenith Award from the Alzheimer’s Association. Internationally recognized, he holds memberships in several academies and has received honors for his contributions to science and education. Dr. Perry’s research focuses on Alzheimer’s disease development and cellular damage caused by oxygen radicals, working toward more effective treatments.
This initiative is made possible thanks to the help of Journal of Alzheimer´s Disease.